Majken Karoline Jensen, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Apolipoprotein C-III | 12 | 2023 | 202 | 4.200 |
Why?
|
| Lipoproteins, HDL | 12 | 2022 | 638 | 3.630 |
Why?
|
| Coronary Disease | 26 | 2020 | 6077 | 2.460 |
Why?
|
| Dementia | 11 | 2024 | 2518 | 2.090 |
Why?
|
| Cholesterol, HDL | 13 | 2022 | 1814 | 2.020 |
Why?
|
| Hemostatics | 2 | 2024 | 229 | 1.420 |
Why?
|
| Denmark | 21 | 2023 | 738 | 1.140 |
Why?
|
| Apolipoprotein A-I | 4 | 2020 | 281 | 0.970 |
Why?
|
| Alcohol Drinking | 22 | 2022 | 3966 | 0.960 |
Why?
|
| Cognition | 8 | 2021 | 6770 | 0.950 |
Why?
|
| Apolipoproteins | 3 | 2022 | 317 | 0.900 |
Why?
|
| Diabetes Mellitus, Type 2 | 15 | 2023 | 11725 | 0.830 |
Why?
|
| Fatty Acids | 5 | 2021 | 1809 | 0.780 |
Why?
|
| Atherosclerosis | 8 | 2022 | 3445 | 0.770 |
Why?
|
| Diet | 16 | 2019 | 7939 | 0.760 |
Why?
|
| Apolipoproteins E | 4 | 2022 | 1438 | 0.750 |
Why?
|
| Phospholipids | 2 | 2021 | 784 | 0.700 |
Why?
|
| Case-Control Studies | 34 | 2021 | 21746 | 0.690 |
Why?
|
| Risk Factors | 69 | 2023 | 72290 | 0.680 |
Why?
|
| Life Style | 11 | 2020 | 3835 | 0.630 |
Why?
|
| Insulin Resistance | 7 | 2023 | 3864 | 0.620 |
Why?
|
| Life Change Events | 1 | 2023 | 938 | 0.620 |
Why?
|
| Biological Specimen Banks | 1 | 2023 | 711 | 0.620 |
Why?
|
| Prospective Studies | 52 | 2024 | 53288 | 0.610 |
Why?
|
| Aged | 82 | 2024 | 163280 | 0.570 |
Why?
|
| Bicycling | 4 | 2018 | 176 | 0.540 |
Why?
|
| Polymorphism, Single Nucleotide | 32 | 2018 | 15519 | 0.530 |
Why?
|
| Alzheimer Disease | 5 | 2022 | 8037 | 0.520 |
Why?
|
| Fishes | 2 | 2016 | 569 | 0.520 |
Why?
|
| Obesity | 12 | 2023 | 12745 | 0.500 |
Why?
|
| Cardiovascular Diseases | 11 | 2023 | 15165 | 0.500 |
Why?
|
| Lipid Metabolism | 3 | 2015 | 1889 | 0.500 |
Why?
|
| Cohort Studies | 38 | 2023 | 40561 | 0.500 |
Why?
|
| Carotid Artery Diseases | 2 | 2018 | 882 | 0.490 |
Why?
|
| Lipoproteins | 2 | 2019 | 878 | 0.490 |
Why?
|
| Genetic Predisposition to Disease | 22 | 2020 | 17446 | 0.490 |
Why?
|
| Polymorphism, Genetic | 7 | 2013 | 4328 | 0.490 |
Why?
|
| Proportional Hazards Models | 22 | 2019 | 12354 | 0.490 |
Why?
|
| Body Mass Index | 15 | 2019 | 12720 | 0.480 |
Why?
|
| Genetic Loci | 8 | 2017 | 2575 | 0.470 |
Why?
|
| Acute Coronary Syndrome | 7 | 2013 | 2337 | 0.470 |
Why?
|
| Models, Cardiovascular | 1 | 2019 | 996 | 0.460 |
Why?
|
| Humans | 150 | 2024 | 744343 | 0.450 |
Why?
|
| Genotype | 17 | 2018 | 12951 | 0.440 |
Why?
|
| Haptoglobins | 4 | 2015 | 165 | 0.440 |
Why?
|
| Middle Aged | 89 | 2021 | 213383 | 0.440 |
Why?
|
| Anthropometry | 2 | 2017 | 1350 | 0.430 |
Why?
|
| Diet, Mediterranean | 3 | 2018 | 700 | 0.430 |
Why?
|
| Male | 101 | 2023 | 350118 | 0.420 |
Why?
|
| Blood Glucose | 6 | 2023 | 6256 | 0.410 |
Why?
|
| Genome-Wide Association Study | 16 | 2019 | 12261 | 0.410 |
Why?
|
| Female | 103 | 2022 | 380194 | 0.400 |
Why?
|
| Lipase | 3 | 2012 | 314 | 0.390 |
Why?
|
| Aged, 80 and over | 27 | 2021 | 57776 | 0.380 |
Why?
|
| Antioxidants | 1 | 2018 | 1663 | 0.370 |
Why?
|
| Dyslipidemias | 1 | 2018 | 849 | 0.370 |
Why?
|
| Genetic Variation | 11 | 2017 | 6544 | 0.350 |
Why?
|
| Cholesterol Ester Transfer Proteins | 2 | 2022 | 110 | 0.340 |
Why?
|
| Incidence | 21 | 2022 | 20947 | 0.340 |
Why?
|
| Homocysteine | 3 | 2015 | 647 | 0.340 |
Why?
|
| Lipoprotein Lipase | 1 | 2009 | 126 | 0.330 |
Why?
|
| Smoking | 12 | 2016 | 8987 | 0.320 |
Why?
|
| Heart Diseases | 2 | 2015 | 2788 | 0.320 |
Why?
|
| Diabetes Mellitus | 4 | 2018 | 5751 | 0.310 |
Why?
|
| Fasting | 2 | 2014 | 1593 | 0.310 |
Why?
|
| Dietary Fiber | 3 | 2009 | 760 | 0.310 |
Why?
|
| Fatty Acid Desaturases | 2 | 2018 | 102 | 0.300 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 627 | 0.300 |
Why?
|
| Adiponectin | 5 | 2017 | 1100 | 0.300 |
Why?
|
| Alcoholism | 4 | 2004 | 1906 | 0.270 |
Why?
|
| Health Expenditures | 3 | 2023 | 2348 | 0.270 |
Why?
|
| Flavonoids | 2 | 2020 | 443 | 0.270 |
Why?
|
| Lipids | 6 | 2017 | 3305 | 0.270 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2017 | 967 | 0.260 |
Why?
|
| Cross-Sectional Studies | 11 | 2023 | 25043 | 0.250 |
Why?
|
| Risk Assessment | 11 | 2020 | 23338 | 0.250 |
Why?
|
| Fibrinogen | 3 | 2024 | 894 | 0.250 |
Why?
|
| Follow-Up Studies | 20 | 2020 | 39050 | 0.250 |
Why?
|
| NF-kappa B | 1 | 2013 | 2499 | 0.240 |
Why?
|
| Sphingomyelins | 2 | 2022 | 105 | 0.240 |
Why?
|
| Proteomics | 3 | 2023 | 3638 | 0.240 |
Why?
|
| Wine | 2 | 2017 | 165 | 0.230 |
Why?
|
| Antithrombin III | 1 | 2024 | 128 | 0.230 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2007 | 560 | 0.230 |
Why?
|
| Multicenter Studies as Topic | 2 | 2020 | 1677 | 0.230 |
Why?
|
| Factor VIIa | 1 | 2024 | 101 | 0.230 |
Why?
|
| Risk | 8 | 2018 | 9687 | 0.220 |
Why?
|
| Overweight | 2 | 2018 | 2371 | 0.220 |
Why?
|
| Adult | 54 | 2021 | 214055 | 0.210 |
Why?
|
| Epidemiologic Studies | 2 | 2023 | 676 | 0.210 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3086 | 0.210 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2013 | 107 | 0.210 |
Why?
|
| Adiposity | 3 | 2019 | 1807 | 0.200 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5867 | 0.200 |
Why?
|
| Thrombin | 1 | 2024 | 598 | 0.200 |
Why?
|
| Stomach Neoplasms | 5 | 2009 | 1333 | 0.190 |
Why?
|
| Antithrombins | 1 | 2024 | 304 | 0.190 |
Why?
|
| Coronary Artery Disease | 2 | 2018 | 6487 | 0.190 |
Why?
|
| Anthocyanins | 1 | 2020 | 79 | 0.180 |
Why?
|
| Glomerular Filtration Rate | 2 | 2019 | 2170 | 0.180 |
Why?
|
| Gene Frequency | 8 | 2017 | 3588 | 0.170 |
Why?
|
| Brain Infarction | 1 | 2021 | 299 | 0.170 |
Why?
|
| Chromosomes, Human, Pair 15 | 2 | 2011 | 373 | 0.170 |
Why?
|
| Europe | 13 | 2018 | 3339 | 0.170 |
Why?
|
| Genetic Association Studies | 5 | 2017 | 2703 | 0.170 |
Why?
|
| Glucose | 2 | 2023 | 4397 | 0.170 |
Why?
|
| Sequence Deletion | 3 | 2013 | 1526 | 0.170 |
Why?
|
| United States | 16 | 2020 | 69872 | 0.170 |
Why?
|
| Mortality | 3 | 2024 | 2864 | 0.170 |
Why?
|
| Sphingosine N-Acyltransferase | 1 | 2018 | 7 | 0.160 |
Why?
|
| Waist Circumference | 2 | 2019 | 917 | 0.160 |
Why?
|
| Dementia, Vascular | 1 | 2019 | 128 | 0.160 |
Why?
|
| Myocardial Infarction | 8 | 2016 | 11727 | 0.160 |
Why?
|
| Bereavement | 1 | 2022 | 277 | 0.160 |
Why?
|
| Triglycerides | 3 | 2023 | 2454 | 0.160 |
Why?
|
| Asparagus Plant | 1 | 2016 | 4 | 0.150 |
Why?
|
| Food Analysis | 1 | 2017 | 104 | 0.140 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2018 | 226 | 0.140 |
Why?
|
| Biomedical Research | 2 | 2024 | 3309 | 0.140 |
Why?
|
| Myosins | 1 | 2018 | 409 | 0.140 |
Why?
|
| Inflammation | 4 | 2015 | 10638 | 0.140 |
Why?
|
| Multivariate Analysis | 4 | 2019 | 12245 | 0.140 |
Why?
|
| Sex Distribution | 4 | 2016 | 2297 | 0.140 |
Why?
|
| Brain Chemistry | 1 | 2020 | 981 | 0.140 |
Why?
|
| Drinking Behavior | 2 | 2019 | 103 | 0.140 |
Why?
|
| Dietary Fats | 3 | 2019 | 2017 | 0.140 |
Why?
|
| Independent Living | 1 | 2020 | 568 | 0.140 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2017 | 194 | 0.140 |
Why?
|
| Alleles | 8 | 2019 | 6933 | 0.140 |
Why?
|
| Uromodulin | 1 | 2015 | 46 | 0.130 |
Why?
|
| Exercise | 4 | 2018 | 5615 | 0.130 |
Why?
|
| Regression Analysis | 2 | 2017 | 6459 | 0.130 |
Why?
|
| Age Distribution | 3 | 2016 | 2902 | 0.130 |
Why?
|
| Helicobacter Infections | 3 | 2008 | 386 | 0.130 |
Why?
|
| Urine | 1 | 2016 | 370 | 0.130 |
Why?
|
| Asymptomatic Diseases | 1 | 2018 | 551 | 0.130 |
Why?
|
| Lipoproteins, VLDL | 1 | 2015 | 201 | 0.120 |
Why?
|
| Insulin | 4 | 2023 | 6580 | 0.120 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 3870 | 0.120 |
Why?
|
| Olfaction Disorders | 1 | 2016 | 222 | 0.120 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2014 | 127 | 0.120 |
Why?
|
| Catalase | 1 | 2014 | 222 | 0.120 |
Why?
|
| Odds Ratio | 7 | 2018 | 9849 | 0.120 |
Why?
|
| Helicobacter pylori | 2 | 2008 | 382 | 0.120 |
Why?
|
| Trans Fatty Acids | 1 | 2014 | 153 | 0.110 |
Why?
|
| Linkage Disequilibrium | 4 | 2018 | 1997 | 0.110 |
Why?
|
| Glutathione Peroxidase | 1 | 2014 | 255 | 0.110 |
Why?
|
| Biological Transport | 1 | 2018 | 2118 | 0.110 |
Why?
|
| Fatty Liver | 2 | 2017 | 727 | 0.110 |
Why?
|
| Longevity | 1 | 2020 | 1070 | 0.110 |
Why?
|
| Longitudinal Studies | 5 | 2018 | 13989 | 0.110 |
Why?
|
| Coffee | 1 | 2017 | 578 | 0.110 |
Why?
|
| Fruit | 3 | 2007 | 1142 | 0.110 |
Why?
|
| Vegetables | 3 | 2007 | 1182 | 0.110 |
Why?
|
| Pericardium | 1 | 2017 | 667 | 0.110 |
Why?
|
| Health Surveys | 2 | 2017 | 4037 | 0.110 |
Why?
|
| Motor Activity | 2 | 2013 | 2714 | 0.100 |
Why?
|
| Homeostasis | 1 | 2023 | 3340 | 0.100 |
Why?
|
| Esophageal Neoplasms | 3 | 2006 | 1583 | 0.100 |
Why?
|
| Receptors, Nicotinic | 2 | 2012 | 497 | 0.100 |
Why?
|
| Alcoholic Beverages | 2 | 2004 | 265 | 0.100 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2011 | 51 | 0.100 |
Why?
|
| Superoxide Dismutase | 1 | 2014 | 597 | 0.100 |
Why?
|
| Cooking | 1 | 2014 | 313 | 0.100 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 300 | 0.100 |
Why?
|
| Registries | 4 | 2023 | 8089 | 0.100 |
Why?
|
| Prevalence | 3 | 2018 | 15226 | 0.100 |
Why?
|
| Linear Models | 2 | 2019 | 5952 | 0.100 |
Why?
|
| Agouti Signaling Protein | 1 | 2011 | 21 | 0.100 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2011 | 68 | 0.100 |
Why?
|
| Up-Regulation | 2 | 2018 | 4217 | 0.100 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2019 | 1541 | 0.100 |
Why?
|
| Prognosis | 4 | 2023 | 29063 | 0.100 |
Why?
|
| Fluorescence | 1 | 2013 | 751 | 0.100 |
Why?
|
| Health Personnel | 5 | 2018 | 3218 | 0.100 |
Why?
|
| Energy Intake | 2 | 2018 | 2148 | 0.090 |
Why?
|
| Liver | 2 | 2017 | 7474 | 0.090 |
Why?
|
| Dietary Sucrose | 1 | 2012 | 246 | 0.090 |
Why?
|
| Mutagenesis, Insertional | 1 | 2013 | 655 | 0.090 |
Why?
|
| Lipoprotein(a) | 1 | 2014 | 435 | 0.090 |
Why?
|
| Aging | 4 | 2024 | 8664 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2011 | 322 | 0.090 |
Why?
|
| Neuropsychological Tests | 2 | 2020 | 6993 | 0.090 |
Why?
|
| Proteome | 1 | 2020 | 1799 | 0.090 |
Why?
|
| Systems Biology | 1 | 2013 | 469 | 0.090 |
Why?
|
| INDEL Mutation | 1 | 2011 | 279 | 0.090 |
Why?
|
| Aortic Valve Stenosis | 1 | 2022 | 1965 | 0.090 |
Why?
|
| Adenocarcinoma | 4 | 2009 | 6364 | 0.090 |
Why?
|
| Research Design | 2 | 2023 | 5987 | 0.090 |
Why?
|
| Aryldialkylphosphatase | 1 | 2009 | 63 | 0.090 |
Why?
|
| Dietary Proteins | 1 | 2014 | 963 | 0.080 |
Why?
|
| Premature Birth | 1 | 2021 | 1721 | 0.080 |
Why?
|
| Bacteria | 1 | 2020 | 2114 | 0.080 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 15076 | 0.080 |
Why?
|
| Sex Factors | 7 | 2017 | 10397 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 12072 | 0.080 |
Why?
|
| Anticoagulants | 1 | 2024 | 4599 | 0.080 |
Why?
|
| Animals | 9 | 2018 | 168757 | 0.080 |
Why?
|
| Fibroblast Growth Factors | 1 | 2014 | 879 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 4740 | 0.080 |
Why?
|
| Heterozygote | 1 | 2015 | 2804 | 0.080 |
Why?
|
| Haplotypes | 3 | 2013 | 2779 | 0.080 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 2849 | 0.080 |
Why?
|
| Feeding Behavior | 2 | 2013 | 3188 | 0.080 |
Why?
|
| E-Selectin | 1 | 2010 | 579 | 0.080 |
Why?
|
| ABO Blood-Group System | 1 | 2010 | 367 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2020 | 2214 | 0.080 |
Why?
|
| Hyperglycemia | 1 | 2016 | 1373 | 0.070 |
Why?
|
| Venous Thromboembolism | 2 | 2017 | 1671 | 0.070 |
Why?
|
| Diabetic Angiopathies | 1 | 2012 | 818 | 0.070 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2007 | 78 | 0.070 |
Why?
|
| Beverages | 1 | 2012 | 820 | 0.070 |
Why?
|
| Amyloid beta-Peptides | 1 | 2020 | 3587 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2009 | 611 | 0.070 |
Why?
|
| Hypertension | 3 | 2012 | 8480 | 0.070 |
Why?
|
| Tobacco Use Disorder | 1 | 2012 | 688 | 0.070 |
Why?
|
| Caffeine | 1 | 2011 | 699 | 0.070 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2006 | 117 | 0.070 |
Why?
|
| Seafood | 1 | 2009 | 384 | 0.070 |
Why?
|
| Colorectal Neoplasms | 2 | 2017 | 6773 | 0.070 |
Why?
|
| PPAR gamma | 1 | 2009 | 493 | 0.070 |
Why?
|
| Coronary Angiography | 1 | 2018 | 4577 | 0.070 |
Why?
|
| Transportation | 2 | 2018 | 214 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2018 | 3297 | 0.070 |
Why?
|
| Double-Blind Method | 1 | 2019 | 12026 | 0.070 |
Why?
|
| Cholesterol | 2 | 2018 | 2917 | 0.070 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2011 | 545 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3279 | 0.060 |
Why?
|
| Diet Surveys | 2 | 2009 | 1173 | 0.060 |
Why?
|
| Nutrition Assessment | 1 | 2007 | 723 | 0.060 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2004 | 65 | 0.060 |
Why?
|
| Logistic Models | 5 | 2016 | 13408 | 0.060 |
Why?
|
| Nurses | 1 | 2013 | 2461 | 0.060 |
Why?
|
| Time Factors | 4 | 2022 | 40075 | 0.060 |
Why?
|
| Coronary Vessels | 1 | 2015 | 3107 | 0.060 |
Why?
|
| Angina, Unstable | 1 | 2008 | 926 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 20129 | 0.060 |
Why?
|
| Vitamin D | 2 | 2014 | 3223 | 0.060 |
Why?
|
| Cadherins | 1 | 2008 | 907 | 0.060 |
Why?
|
| C-Reactive Protein | 3 | 2015 | 3778 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2268 | 0.060 |
Why?
|
| Meat | 1 | 2006 | 592 | 0.050 |
Why?
|
| Intermediate Filaments | 1 | 2023 | 175 | 0.050 |
Why?
|
| Laryngeal Neoplasms | 1 | 2006 | 512 | 0.050 |
Why?
|
| Health Behavior | 2 | 2018 | 2636 | 0.050 |
Why?
|
| Clinical Trials as Topic | 1 | 2018 | 7913 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 2538 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 4462 | 0.050 |
Why?
|
| Beer | 1 | 2002 | 127 | 0.050 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2023 | 528 | 0.050 |
Why?
|
| Heart Rate | 1 | 2013 | 4091 | 0.050 |
Why?
|
| Base Sequence | 1 | 2013 | 12797 | 0.050 |
Why?
|
| Phenotype | 3 | 2024 | 16365 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 10943 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2016 | 5102 | 0.050 |
Why?
|
| Mouth Neoplasms | 1 | 2006 | 601 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2006 | 2971 | 0.050 |
Why?
|
| Chi-Square Distribution | 3 | 2017 | 3508 | 0.050 |
Why?
|
| Ceramides | 1 | 2022 | 199 | 0.050 |
Why?
|
| Nonlinear Dynamics | 1 | 2003 | 502 | 0.050 |
Why?
|
| Grief | 1 | 2022 | 247 | 0.040 |
Why?
|
| Subcutaneous Fat, Abdominal | 1 | 2020 | 93 | 0.040 |
Why?
|
| Proteins | 1 | 2014 | 6103 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2011 | 14557 | 0.040 |
Why?
|
| Nutritional Status | 1 | 2007 | 1609 | 0.040 |
Why?
|
| Rectal Neoplasms | 1 | 2007 | 1206 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2008 | 1470 | 0.040 |
Why?
|
| Singapore | 1 | 2019 | 295 | 0.040 |
Why?
|
| Lactase | 1 | 2018 | 69 | 0.040 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 1150 | 0.040 |
Why?
|
| Leptin | 1 | 2006 | 1599 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2011 | 4034 | 0.040 |
Why?
|
| Body Weight | 2 | 2018 | 4669 | 0.040 |
Why?
|
| Leisure Activities | 1 | 2018 | 311 | 0.040 |
Why?
|
| Brain | 2 | 2022 | 26385 | 0.040 |
Why?
|
| Linoleic Acid | 1 | 2017 | 157 | 0.030 |
Why?
|
| Glycolysis | 1 | 2020 | 827 | 0.030 |
Why?
|
| Apolipoproteins C | 1 | 2015 | 59 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 764 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2006 | 3200 | 0.030 |
Why?
|
| Recreation | 1 | 2016 | 115 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2011 | 8554 | 0.030 |
Why?
|
| Morbidity | 1 | 2021 | 1769 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2007 | 2541 | 0.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 3047 | 0.030 |
Why?
|
| Tea | 1 | 2017 | 275 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2020 | 748 | 0.030 |
Why?
|
| Probability | 1 | 2021 | 2505 | 0.030 |
Why?
|
| Prostatic Neoplasms | 2 | 2009 | 11124 | 0.030 |
Why?
|
| Particle Size | 1 | 2019 | 1642 | 0.030 |
Why?
|
| Factor VII | 1 | 2015 | 139 | 0.030 |
Why?
|
| Introns | 1 | 2018 | 991 | 0.030 |
Why?
|
| Apolipoprotein E4 | 1 | 2019 | 668 | 0.030 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 361 | 0.030 |
Why?
|
| Smell | 1 | 2016 | 244 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2020 | 591 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2015 | 623 | 0.030 |
Why?
|
| Data Collection | 2 | 2018 | 3341 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2015 | 528 | 0.030 |
Why?
|
| Lung Neoplasms | 2 | 2010 | 13102 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 546 | 0.030 |
Why?
|
| Multigene Family | 1 | 2017 | 1102 | 0.030 |
Why?
|
| Calcinosis | 1 | 2022 | 1499 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2014 | 434 | 0.030 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2014 | 227 | 0.030 |
Why?
|
| Depression | 1 | 2013 | 7766 | 0.030 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 789 | 0.030 |
Why?
|
| China | 1 | 2019 | 2248 | 0.030 |
Why?
|
| Drug Discovery | 1 | 2020 | 1058 | 0.030 |
Why?
|
| Population Surveillance | 1 | 2003 | 2616 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 845 | 0.030 |
Why?
|
| Gestational Age | 1 | 2021 | 3493 | 0.030 |
Why?
|
| Biometry | 1 | 2015 | 558 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2022 | 1922 | 0.030 |
Why?
|
| Pharmaceutical Preparations | 1 | 2020 | 1071 | 0.030 |
Why?
|
| Models, Biological | 2 | 2024 | 9583 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2016 | 6196 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 403 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 2011 | 5686 | 0.020 |
Why?
|
| Albuminuria | 1 | 2015 | 682 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2009 | 5256 | 0.020 |
Why?
|
| tau Proteins | 1 | 2020 | 1868 | 0.020 |
Why?
|
| Pigmentation | 1 | 2011 | 148 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 2011 | 374 | 0.020 |
Why?
|
| Memory | 1 | 2020 | 2174 | 0.020 |
Why?
|
| Shellfish | 1 | 2009 | 38 | 0.020 |
Why?
|
| Creatinine | 1 | 2015 | 1919 | 0.020 |
Why?
|
| Mice | 3 | 2011 | 81183 | 0.020 |
Why?
|
| Glycosylation | 1 | 2013 | 1126 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2017 | 1224 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2014 | 906 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2009 | 2282 | 0.020 |
Why?
|
| Solubility | 1 | 2011 | 1085 | 0.020 |
Why?
|
| Food Handling | 1 | 2009 | 145 | 0.020 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2011 | 209 | 0.020 |
Why?
|
| Adolescent Development | 1 | 2012 | 278 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2015 | 1602 | 0.020 |
Why?
|
| Self Report | 1 | 2020 | 3558 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2016 | 1504 | 0.020 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2013 | 783 | 0.020 |
Why?
|
| Evolution, Molecular | 1 | 2017 | 1940 | 0.020 |
Why?
|
| Quality Control | 1 | 2011 | 841 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2011 | 640 | 0.020 |
Why?
|
| Nutritional Sciences | 1 | 2009 | 137 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2020 | 35421 | 0.020 |
Why?
|
| Nicotine | 1 | 2012 | 681 | 0.020 |
Why?
|
| Proline | 1 | 2009 | 458 | 0.020 |
Why?
|
| Heart Conduction System | 1 | 2013 | 1047 | 0.020 |
Why?
|
| Hippocampus | 1 | 2020 | 3675 | 0.020 |
Why?
|
| Blood Pressure Determination | 1 | 2011 | 634 | 0.020 |
Why?
|
| Weight Gain | 1 | 2017 | 2292 | 0.020 |
Why?
|
| Medical Audit | 1 | 2008 | 467 | 0.020 |
Why?
|
| Alanine | 1 | 2009 | 572 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 1252 | 0.020 |
Why?
|
| Hospitalization | 2 | 2021 | 10262 | 0.020 |
Why?
|
| Cardia | 1 | 2006 | 57 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4803 | 0.020 |
Why?
|
| Protein Binding | 1 | 2018 | 9386 | 0.020 |
Why?
|
| Age of Onset | 1 | 2012 | 3271 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 2019 | 0.020 |
Why?
|
| Age Factors | 2 | 2017 | 18370 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2017 | 3670 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1791 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7659 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 6234 | 0.010 |
Why?
|
| Young Adult | 3 | 2018 | 56430 | 0.010 |
Why?
|
| Exons | 1 | 2009 | 2437 | 0.010 |
Why?
|
| Epidemiologic Methods | 1 | 2008 | 1364 | 0.010 |
Why?
|
| Medical Records | 1 | 2008 | 1413 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2015 | 10252 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2012 | 2356 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10388 | 0.010 |
Why?
|
| Residence Characteristics | 1 | 2012 | 2050 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 19905 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 7785 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 25625 | 0.010 |
Why?
|
| Neurons | 1 | 2020 | 9338 | 0.010 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2009 | 1344 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2007 | 20822 | 0.010 |
Why?
|
| Pregnancy | 1 | 2021 | 29144 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8324 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13881 | 0.010 |
Why?
|
| Disease Progression | 1 | 2015 | 13284 | 0.010 |
Why?
|
| Gene Expression | 1 | 2011 | 7799 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 2886 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2008 | 4026 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 2007 | 2585 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 15540 | 0.010 |
Why?
|
| Rats | 1 | 2011 | 24260 | 0.010 |
Why?
|
| Cause of Death | 1 | 2004 | 3584 | 0.010 |
Why?
|
| Adolescent | 2 | 2012 | 85781 | 0.010 |
Why?
|
| Heart Failure | 1 | 2015 | 10900 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2009 | 21827 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 9959 | 0.010 |
Why?
|
| Mutation | 1 | 2009 | 29786 | 0.000 |
Why?
|